Take Action Today: Support the Pharmacists Fight Back Act
The Pharmacists Fight Back Act returns with bipartisan backing and a real chance to rein in PBM abuses. Contact your Representative today and help push these critical reforms forward.
APCI tracks and reports on pharmacy public policy developments, including PBM reform efforts, legislative activity, and regulatory changes impacting independent pharmacies.
APCI tracks and reports on pharmacy public policy developments, including PBM reform efforts, legislative activity, and regulatory changes impacting independent pharmacies.
The Pharmacists Fight Back Act returns with bipartisan backing and a real chance to rein in PBM abuses. Contact your Representative today and help push these critical reforms forward.
Missed the live event? Watch the full press conference on the reintroduction of the Pharmacists Fight Back Act and hear directly from advocates and policymakers pushing for federal PBM reform.
Two companion bills revive the Pharmacists Fight Back Act, targeting PBM abuses and calling on pharmacists to engage and take action.
Alabama’s new PBM reform law delivers greater transparency, fair reimbursement, and stronger protections for patients and independent pharmacies.
APCI looks back at a pivotal year for PBM reform, including the introduction of the Pharmacists Fight Back Act, growing congressional support, national policy events, state-level advocacy, and APCI’s ongoing efforts to protect independent pharmacies and their patients.
Watch top moments from lawmakers in 2024 calling out PBM abuses and pushing for meaningful reform.
Bipartisan lawmakers highlight growing momentum for the Pharmacists Fight Back Act, with a press conference underscoring support for comprehensive PBM reform.
Miss the webcast? Watch the full Pharmacists Fight Back Act overview and take action by urging your Representative to support the bill.
The closure of a Georgia independent pharmacy highlights stark PBM reimbursement disparities, sparking outrage from lawmakers and renewed calls for reform.
APCI urges the DOJ to block Optum’s acquisition of Amedisys, warning that deeper insurer-PBM integration threatens competition, patient choice, and the integrity of care.